1. Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide
   Md Wahiduzzaman et al, 2020, Current Cancer Drug Targets CrossRef
2. Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma
   Sze-Kwan Lam et al, 2019, Oncogenesis CrossRef
3. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts
   Sze-Kwan Lam et al, 2017, Respiratory Research CrossRef
4. Targeting polyamine as a novel therapy in xenograft models of malignant pleural mesothelioma
   Sze-Kwan Lam et al, 2020, Lung Cancer CrossRef
5. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma
   Sze-Kwan Lam et al, 2016, Lung Cancer CrossRef
6. Cytotoxicity and genotoxicity effects of arsenic trioxide on SQ20B human laryngeal carcinoma cells
   Fatma Trabelsi et al, 2017, Experimental and Toxicologic Pathology CrossRef
7. A self-assembled RNA-triple helix hydrogel drug delivery system targeting triple-negative breast cancer
   Lairong Ding et al, 2020, Journal of Materials Chemistry B CrossRef
8. What can independent research for mesothelioma achieve to treat this orphan disease?
   Alice Guazzelli et al, 2019, Expert Opinion on Investigational Drugs CrossRef
9. Arsenic: A Review of the Element’s Toxicity, Plant Interactions, and Potential Methods of Remediation
   Bryan E. Hettick et al, 2015, Journal of Agricultural and Food Chemistry CrossRef
10. Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
    Arnaud Boyer et al, 2018, European Respiratory Review CrossRef
11. Arsenic trioxide reduces the expression of E2F1, cyclin E, and phosphorylation of PI3K signaling molecules in acute leukemia cells
    Sanjay Kumar et al, 2021, Environmental Toxicology CrossRef